 Mona Abaza
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 10 | 2021 | 84 | 3.060 |
Why?
| | Voice Disorders | 9 | 2017 | 22 | 1.700 |
Why?
| | Personnel Selection | 4 | 2019 | 73 | 1.360 |
Why?
| | Internship and Residency | 8 | 2019 | 1054 | 1.340 |
Why?
| | Laryngoscopy | 4 | 2023 | 100 | 0.820 |
Why?
| | Larynx | 4 | 2015 | 55 | 0.770 |
Why?
| | Physicians, Women | 1 | 2021 | 72 | 0.690 |
Why?
| | Learning | 1 | 2023 | 390 | 0.630 |
Why?
| | Leadership | 2 | 2021 | 356 | 0.580 |
Why?
| | Treatment Adherence and Compliance | 1 | 2017 | 22 | 0.560 |
Why?
| | Career Choice | 1 | 2018 | 211 | 0.520 |
Why?
| | Resilience, Psychological | 1 | 2018 | 119 | 0.510 |
Why?
| | Deglutition Disorders | 1 | 2017 | 129 | 0.500 |
Why?
| | Injections | 1 | 2015 | 170 | 0.470 |
Why?
| | Education, Medical | 1 | 2018 | 244 | 0.470 |
Why?
| | Simulation Training | 1 | 2015 | 82 | 0.440 |
Why?
| | Voice | 2 | 2017 | 11 | 0.430 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 177 | 0.420 |
Why?
| | Patient Care Team | 1 | 2017 | 600 | 0.390 |
Why?
| | Occupational Diseases | 2 | 2006 | 141 | 0.390 |
Why?
| | Vocal Cords | 4 | 2006 | 32 | 0.380 |
Why?
| | Burnout, Professional | 1 | 2018 | 408 | 0.380 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2020 | 269 | 0.360 |
Why?
| | Hepatitis C | 2 | 2020 | 233 | 0.360 |
Why?
| | Education, Medical, Graduate | 3 | 2019 | 436 | 0.320 |
Why?
| | Liver Neoplasms | 2 | 2020 | 640 | 0.300 |
Why?
| | Inhibin-beta Subunits | 1 | 2006 | 5 | 0.260 |
Why?
| | Activins | 1 | 2006 | 27 | 0.260 |
Why?
| | Schistosomiasis | 1 | 2006 | 38 | 0.250 |
Why?
| | Job Application | 2 | 2015 | 13 | 0.230 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2006 | 307 | 0.220 |
Why?
| | Postpoliomyelitis Syndrome | 1 | 2001 | 4 | 0.190 |
Why?
| | Humans | 26 | 2023 | 128524 | 0.190 |
Why?
| | Glypicans | 1 | 2020 | 9 | 0.180 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2020 | 13 | 0.180 |
Why?
| | Neurofibromatosis 2 | 2 | 1998 | 4 | 0.170 |
Why?
| | Equipment Design | 2 | 2015 | 518 | 0.170 |
Why?
| | Voice Quality | 2 | 2014 | 17 | 0.160 |
Why?
| | Pilot Projects | 2 | 2019 | 1558 | 0.160 |
Why?
| | Disability Evaluation | 1 | 2000 | 289 | 0.150 |
Why?
| | Otolaryngologists | 1 | 2017 | 10 | 0.140 |
Why?
| | United States | 4 | 2019 | 13876 | 0.140 |
Why?
| | Speech-Language Pathology | 1 | 2017 | 19 | 0.140 |
Why?
| | Organizational Culture | 1 | 2018 | 137 | 0.130 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.130 |
Why?
| | Interviews as Topic | 1 | 2019 | 705 | 0.130 |
Why?
| | Competitive Behavior | 1 | 2015 | 41 | 0.120 |
Why?
| | Psychoses, Substance-Induced | 2 | 2007 | 14 | 0.120 |
Why?
| | Dysphonia | 1 | 2014 | 13 | 0.120 |
Why?
| | Speech Acoustics | 1 | 2014 | 12 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2018 | 265 | 0.120 |
Why?
| | Clinical Clerkship | 1 | 2016 | 94 | 0.110 |
Why?
| | Cell Division | 1 | 1996 | 779 | 0.110 |
Why?
| | Female | 13 | 2021 | 68127 | 0.110 |
Why?
| | Program Evaluation | 1 | 2018 | 874 | 0.110 |
Why?
| | Egypt | 2 | 2020 | 10 | 0.110 |
Why?
| | Electromyography | 3 | 2007 | 380 | 0.110 |
Why?
| | Clinical Competence | 2 | 2019 | 1014 | 0.110 |
Why?
| | School Admission Criteria | 1 | 2013 | 23 | 0.110 |
Why?
| | Educational Measurement | 1 | 2016 | 261 | 0.110 |
Why?
| | Attitude | 1 | 2015 | 250 | 0.100 |
Why?
| | Correspondence as Topic | 1 | 2012 | 14 | 0.100 |
Why?
| | Societies, Medical | 1 | 2016 | 749 | 0.100 |
Why?
| | Students, Medical | 1 | 2016 | 314 | 0.090 |
Why?
| | Male | 13 | 2018 | 62883 | 0.090 |
Why?
| | Writing | 1 | 2012 | 94 | 0.090 |
Why?
| | Surgeons | 1 | 2015 | 274 | 0.090 |
Why?
| | Nasal Decongestants | 2 | 2007 | 8 | 0.080 |
Why?
| | Anti-Ulcer Agents | 2 | 2007 | 14 | 0.080 |
Why?
| | Histamine H1 Antagonists | 2 | 2007 | 29 | 0.080 |
Why?
| | Biomedical Research | 1 | 2015 | 646 | 0.080 |
Why?
| | Vocal Cord Paralysis | 2 | 2005 | 29 | 0.070 |
Why?
| | Analgesics | 1 | 2007 | 165 | 0.060 |
Why?
| | Music | 1 | 2006 | 39 | 0.060 |
Why?
| | Movement Disorders | 1 | 2005 | 52 | 0.060 |
Why?
| | Vagus Nerve Diseases | 1 | 2002 | 1 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2007 | 575 | 0.050 |
Why?
| | Severity of Illness Index | 3 | 2014 | 2736 | 0.050 |
Why?
| | Cough | 1 | 2002 | 116 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2001 | 27 | 0.050 |
Why?
| | Amyloidosis | 1 | 2001 | 39 | 0.050 |
Why?
| | Myasthenia Gravis | 1 | 2001 | 22 | 0.040 |
Why?
| | Cicatrix | 1 | 2001 | 58 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2020 | 39 | 0.040 |
Why?
| | Middle Aged | 7 | 2006 | 30893 | 0.040 |
Why?
| | Gastroesophageal Reflux | 1 | 2002 | 232 | 0.040 |
Why?
| | Audiometry, Pure-Tone | 2 | 1998 | 27 | 0.040 |
Why?
| | Parkinson Disease | 1 | 2005 | 451 | 0.040 |
Why?
| | Adult | 6 | 2006 | 35315 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2001 | 250 | 0.040 |
Why?
| | Hepacivirus | 1 | 2020 | 234 | 0.040 |
Why?
| | Ear Neoplasms | 1 | 1998 | 8 | 0.040 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2001 | 255 | 0.040 |
Why?
| | Acute Disease | 1 | 2001 | 968 | 0.040 |
Why?
| | Neurilemmoma | 1 | 1998 | 22 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2001 | 591 | 0.030 |
Why?
| | Stroke | 1 | 2005 | 1064 | 0.030 |
Why?
| | Spinal Neoplasms | 1 | 1996 | 29 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2014 | 3023 | 0.030 |
Why?
| | Speech Production Measurement | 1 | 2014 | 12 | 0.030 |
Why?
| | Hearing Loss | 1 | 1998 | 209 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2001 | 4898 | 0.030 |
Why?
| | Judgment | 1 | 2014 | 56 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 281 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1182 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 143 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 315 | 0.030 |
Why?
| | Speech Perception | 1 | 2014 | 82 | 0.030 |
Why?
| | ROC Curve | 1 | 2014 | 501 | 0.030 |
Why?
| | Prospective Studies | 2 | 2014 | 7043 | 0.020 |
Why?
| | Aged | 4 | 2005 | 21971 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3881 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2014 | 1936 | 0.020 |
Why?
| | Patient Selection | 1 | 2012 | 661 | 0.020 |
Why?
| | Age Factors | 1 | 1996 | 3117 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 1998 | 3366 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2014 | 3326 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1616 | 0.020 |
Why?
| | Risk Assessment | 2 | 2005 | 3256 | 0.010 |
Why?
| | Age Distribution | 1 | 2005 | 376 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 359 | 0.010 |
Why?
| | Brain | 1 | 1996 | 2618 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5040 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 5346 | 0.010 |
Why?
| | Hoarseness | 1 | 2001 | 4 | 0.010 |
Why?
| | Pyridostigmine Bromide | 1 | 2001 | 5 | 0.010 |
Why?
| | Laryngeal Muscles | 1 | 2001 | 6 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2001 | 33 | 0.010 |
Why?
| | Cholinesterase Inhibitors | 1 | 2001 | 28 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2001 | 117 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2001 | 189 | 0.010 |
Why?
| | Medical History Taking | 1 | 2001 | 115 | 0.010 |
Why?
| | Drug Therapy | 1 | 2001 | 76 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2001 | 215 | 0.010 |
Why?
| | Steroids | 1 | 2001 | 148 | 0.010 |
Why?
| | Drug Utilization | 1 | 2001 | 167 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2619 | 0.010 |
Why?
| | Speech Reception Threshold Test | 1 | 1998 | 1 | 0.010 |
Why?
| | Retrospective Studies | 3 | 2001 | 14460 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1416 | 0.010 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 1998 | 10 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 2001 | 469 | 0.010 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 1998 | 51 | 0.010 |
Why?
| | Prognosis | 1 | 2005 | 3780 | 0.010 |
Why?
| | Adolescent | 1 | 1996 | 20213 | 0.010 |
Why?
| | Chronic Disease | 1 | 2002 | 1701 | 0.010 |
Why?
| | Child | 1 | 1996 | 20721 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 7040 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2001 | 1266 | 0.010 |
Why?
| | Risk Factors | 1 | 2001 | 9727 | 0.000 |
Why?
| | Treatment Outcome | 1 | 2001 | 10163 | 0.000 |
Why?
|
|
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|